Investment
Features
FeesSafety
Academy
More
Pluang+

CACI International rated hold as it shifts to tech-driven growth despite lagging profitability.

Analyst Insights
15 Aug 2026
Seeking Alpha
View Source
Neutral
CACI International rated hold as it shifts to tech-driven growth despite lagging profitability.

CACI International, a leading government and IT contractor with a $14 billion market cap, is rated a hold due to lagging profitability despite strong growth metrics. The company is pivoting towards technology-driven contracts, especially in defense, allowing it to bid aggressively on proprietary tech work compared to peers focusing on cost-plus contracts. This strategic shift has driven recent stock rallies as the market anticipates more contract wins. However, earnings multiples remain in line with sector averages, reflecting cautious investor sentiment.

More News

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Two directors of Equitable Holdings sold shares recently, with Bertram L. Scott selling 2,780 shares and Craig C. MacKay selling 2,000 shares. Meanwhile, institutional investors showed mixed activity: Engineers Gate Manager LP drastically cut its hol...

Market News
Neutral
2 hours ago
Greenland mining and chip ETFs soar on new security deal and AI optimism

Greenland mining and chip ETFs soar on new security deal and AI optimism

Shares of Greenland-linked mining companies surged following a new U.S.-Denmark-Greenland security agreement that boosted investor interest in Greenland's mineral resources. Greenland Mines Ltd. jumped over 229%, while Critical Metals Corp. rose near...

Market News
Bullish
2 hours ago
Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs were the biggest losers in the market, with Cue Biopharma dropping 23.7% despite positive Phase 2 clinical results. Leveraged ETFs tied to AMD, Strategy, and Novo Nordisk also saw sharp declines due to their daily-re...

Market News
Bearish
2 hours ago
Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology Holdings is being taken private in a $1.6 billion deal led by its Chairman and CEO, Thomas Priore. The acquisition price is $8.05 per share, matching the analyst price target set by Lake Street, which downgraded the stock to 'Hold...

Company Fundamentals
Neutral
3 hours ago
General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills is set to report its Q3 2026 earnings with an expected 16.3% decline in earnings per share to $0.72 and revenue forecast around $4.35 billion, down from last year. Despite these declines, the company reaffirmed its full-year adjusted EP...

Company Fundamentals
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App